Konstantin Tsoyi

2.0k total citations
36 papers, 1.7k citations indexed

About

Konstantin Tsoyi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Konstantin Tsoyi has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 5 papers in Pharmacology. Recurrent topics in Konstantin Tsoyi's work include Heme Oxygenase-1 and Carbon Monoxide (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Advanced Glycation End Products research (5 papers). Konstantin Tsoyi is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (12 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Advanced Glycation End Products research (5 papers). Konstantin Tsoyi collaborates with scholars based in United States, South Korea and China. Konstantin Tsoyi's co-authors include Hye Jung Kim, Jae Heun Lee, Han Geuk Seo, Ki Churl Chang, Young Soo Lee, Hwa Jin Jang, Young‐Min Kim, Mark A. Perrella, Xiaoli Liu and Bonna Ith and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Journal of Agricultural and Food Chemistry.

In The Last Decade

Konstantin Tsoyi

34 papers receiving 1.6k citations

Peers

Konstantin Tsoyi
Jian Feng China
Se‐Ran Yang South Korea
Jizhong Cheng United States
Mi Ra Yu South Korea
Sudha Ananth United States
Qin Chen China
Gi Ryang Kweon South Korea
Jian Feng China
Konstantin Tsoyi
Citations per year, relative to Konstantin Tsoyi Konstantin Tsoyi (= 1×) peers Jian Feng

Countries citing papers authored by Konstantin Tsoyi

Since Specialization
Citations

This map shows the geographic impact of Konstantin Tsoyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstantin Tsoyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstantin Tsoyi more than expected).

Fields of papers citing papers by Konstantin Tsoyi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konstantin Tsoyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstantin Tsoyi. The network helps show where Konstantin Tsoyi may publish in the future.

Co-authorship network of co-authors of Konstantin Tsoyi

This figure shows the co-authorship network connecting the top 25 collaborators of Konstantin Tsoyi. A scholar is included among the top collaborators of Konstantin Tsoyi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konstantin Tsoyi. Konstantin Tsoyi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McKenna, Neil J., Scott A. Ochsner, B.J. Moss, et al.. (2025). Single Cell Transcriptomics in a Treatment Status Segregated Cohort Exposes a STAT3-Regulated Therapeutic Gap in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5273–A5273.
2.
Sánchez, Santiago, Scott A. Ochsner, Neil J. McKenna, et al.. (2024). PIK-III exerts anti-fibrotic effects in activated fibroblasts by regulating p38 activation. PLoS ONE. 19(9). e0306624–e0306624. 1 indexed citations
3.
Lim, Clarice X., Alexandre F. Carisey, Scott A. Ochsner, et al.. (2023). SHP2 promotes sarcoidosis severity by inhibiting SKP2-targeted ubiquitination of TBET in CD8 + T cells. Science Translational Medicine. 15(713). eade2581–eade2581. 3 indexed citations
4.
Sun, Bo, Ronak Tilvawala, Konstantin Tsoyi, et al.. (2023). Peptidylarginine deiminase 2 citrullinates MZB1 and promotes the secretion of IgM and IgA. Frontiers in Immunology. 14. 1290585–1290585. 4 indexed citations
5.
Tsoyi, Konstantin, Anthony J. Esposito, Bo Sun, et al.. (2022). Syndecan-2 regulates PAD2 to exert antifibrotic effects on RA-ILD fibroblasts. Scientific Reports. 12(1). 2847–2847. 9 indexed citations
6.
Sun, Bo, Ari J. Salinger, Ronak Tilvawala, et al.. (2021). PAD2-mediated citrullination of Fibulin-5 promotes elastogenesis. Matrix Biology. 102. 70–84. 11 indexed citations
7.
Tsoyi, Konstantin, Xiaoliang Liang, Giulia De Rossi, et al.. (2021). CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 204(3). 312–325. 38 indexed citations
8.
Hettiarachchi, Suraj U., Jyoti Roy, Fenghua Zhang, et al.. (2020). Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models. Science Translational Medicine. 12(567). 69 indexed citations
9.
Chu, Sarah, Julian A. Villalba, Xiaoliang Liang, et al.. (2019). Palmitic Acid–Rich High-Fat Diet Exacerbates Experimental Pulmonary Fibrosis by Modulating Endoplasmic Reticulum Stress. American Journal of Respiratory Cell and Molecular Biology. 61(6). 737–746. 89 indexed citations
10.
Chu, Sarah, Sergio Poli, Yuichi Sakairi, et al.. (2019). Biobanking and cryopreservation of human lung explants for omic analysis. European Respiratory Journal. 55(1). 1801635–1801635. 11 indexed citations
11.
Tsoyi, Konstantin, Juan C. Osorio, Sarah Chu, et al.. (2018). Lung Adenocarcinoma Syndecan-2 Potentiates Cell Invasiveness. American Journal of Respiratory Cell and Molecular Biology. 60(6). 659–666. 19 indexed citations
12.
Tsoyi, Konstantin, Sarah Chu, Julie A. Wilder, et al.. (2017). Syndecan-2 Attenuates Radiation-induced Pulmonary Fibrosis and Inhibits Fibroblast Activation by Regulating PI3K/Akt/ROCK Pathway via CD148. American Journal of Respiratory Cell and Molecular Biology. 58(2). 208–215. 57 indexed citations
13.
Ghanta, Sailaja, Konstantin Tsoyi, Xiaoli Liu, et al.. (2016). Mesenchymal Stromal Cells Deficient in Autophagy Proteins Are Susceptible to Oxidative Injury and Mitochondrial Dysfunction. American Journal of Respiratory Cell and Molecular Biology. 56(3). 300–309. 37 indexed citations
14.
Kim, Young‐Min, Konstantin Tsoyi, Hwa Jin Jang, et al.. (2014). CKD712, a synthetic isoquinoline alkaloid, enhances the anti-cancer effects of paclitaxel in MDA-MB-231 cells through regulation of PTEN. Life Sciences. 112(1-2). 49–58. 10 indexed citations
15.
Park, Eun‐Jung, Hwa Jin Jang, Konstantin Tsoyi, et al.. (2013). The Heme Oxygenase-1 Inducer THI-56 Negatively Regulates iNOS Expression and HMGB1 Release in LPS-Activated RAW 264.7 Cells and CLP-Induced Septic Mice. PLoS ONE. 8(10). e76293–e76293. 19 indexed citations
16.
Tsoyi, Konstantin, Hwa Jin Jang, Young Soo Lee, et al.. (2011). (+)-Nootkatone and (+)-valencene from rhizomes of Cyperus rotundus increase survival rates in septic mice due to heme oxygenase-1 induction. Journal of Ethnopharmacology. 137(3). 1311–1317. 83 indexed citations
17.
Tsoyi, Konstantin, Hwa Jin Jang, Irina Tsoy Nizamutdinova, et al.. (2010). PTEN differentially regulates expressions of ICAM-1 and VCAM-1 through PI3K/Akt/GSK-3β/GATA-6 signaling pathways in TNF-α-activated human endothelial cells. Atherosclerosis. 213(1). 115–121. 63 indexed citations
18.
Tsoyi, Konstantin, Irina Tsoy Nizamutdinova, Hwa Jin Jang, et al.. (2010). Carbon Monoxide From CORM-2 Reduces HMGB1 Release Through Regulation of IFN-β/JAK2/STAT-1/INOS/NO Signaling But Not COX-2 in TLR-Activated Macrophages. Shock. 34(6). 608–614. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026